Efficacy of Treatment Sequences in Patients With Non-small Cell Lung Cancer Receiving Lorlatinib
Clinical trial NCT03727477 · COMPLETED
Trial details
- NCT number
- NCT03727477
- Sponsor
- Intergroupe Francophone de Cancerologie Thoracique
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-02-01
- Primary completion
- 2020-10-12
- Enrollment
- 291
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.